MedPath
NMPA Approval

Efgartigimod Alfa Injection (Subcutaneous Injection)

国药准字SJ20240029

ARGENX BV

July 9, 2024

Drug Information

艾加莫德α注射液(皮下注射)

卫力迦

注射剂

1000mg(5.6ml)/瓶

生物制品

July 9, 2024

July 8, 2029

Company Information

Applicant Company

ARGENX BV

Industriepark Zwijnaarde 7, 9052 Zwijnaarde, Belgium

Manufacturing Company

PATHEON ITALIA SPA

2° Trav. SX Via Morolense, 5-03013 Ferentino (FR), Italy

© Copyright 2025. All Rights Reserved by MedPath
艾加莫德α注射液(皮下注射) - NMPA 批准文号 | MedPath